HomeCompareEDTXF vs MO

EDTXF vs MO: Dividend Comparison 2026

EDTXF yields 203.25% · MO yields 6.27%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EDTXF wins by $131.01M in total portfolio value
10 years
EDTXF
EDTXF
● Live price
203.25%
Share price
$0.98
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$131.09M
Annual income
$66,614,308.55
Full EDTXF calculator →
MO
Altria Group Inc.
● Live price
6.27%
Share price
$67.02
Annual div
$4.20
5Y div CAGR
22.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$77.7K
Annual income
$28,968.54
Full MO calculator →

Portfolio growth — EDTXF vs MO

📍 EDTXF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEDTXFMO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EDTXF + MO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
EDTXF pays
MO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EDTXF
Annual income on $10K today (after 15% tax)
$17,276.42/yr
After 10yr DRIP, annual income (after tax)
$56,622,162.27/yr
MO
Annual income on $10K today (after 15% tax)
$532.68/yr
After 10yr DRIP, annual income (after tax)
$24,623.26/yr
At 15% tax rate, EDTXF beats the other by $56,597,539.01/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EDTXF + MO for your $10,000?

EDTXF: 50%MO: 50%
100% MO50/50100% EDTXF
Portfolio after 10yr
$65.58M
Annual income
$33,321,638.54/yr
Blended yield
50.81%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MO right now

EDTXF
No analyst data
Altman Z
-75.3
Piotroski
2/9
MO
Analyst Ratings
16
Buy
9
Hold
1
Sell
Consensus: Buy
Price Target
$61.25
-8.6% upside vs current
Range: $47.00 — $68.00
Altman Z
3.2
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EDTXF buys
0
MO buys
11
PoliticianChamberTickerTypeAmountDate
Ro Khanna🏢 House$MO▲ Buy$1,000 - $15,0002025-08-04
Sheri Biggs🏢 House$MO▼ Sell$1,001 - $15,0002025-03-19
Pete Sessions🏢 House$MO▼ Sell$1,001 - $15,0002024-09-10
Ro Khanna🏢 House$MO▲ Buy$1,001 - $15,0002024-03-20
Ro Khanna🏢 House$MO▲ Buy$1,001 - $15,0002024-02-13
Virginia Foxx🏢 House$MO▼ Sell$1,001 - $15,0002024-01-16
Virginia Foxx🏢 House$MO▲ Buy$1,001 - $15,0002024-01-11
Ro Khanna🏢 House$MO▼ Sell$1,001 - $15,0002024-01-10
Ro Khanna🏢 House$MO▲ Buy$1,001 - $15,0002024-01-10
Virginia Foxx🏢 House$MO▼ Sell$15,001 - $50,0002024-01-10
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEDTXFMO
Forward yield203.25%6.27%
Annual dividend / share$2.00$4.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%22.6%
Portfolio after 10y$131.09M$77.7K
Annual income after 10y$66,614,308.55$28,968.54
Total dividends collected$123.65M$72.0K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: EDTXF vs MO ($10,000, DRIP)

YearEDTXF PortfolioEDTXF Income/yrMO PortfolioMO Income/yrGap
1← crossover$31,025$20,325.20$10,558$768.31+$20.5KEDTXF
2$92,131$58,933.98$11,352$1,015.87+$80.8KEDTXF
3$262,139$163,558.41$12,482$1,367.86+$249.7KEDTXF
4$715,413$434,925.03$14,103$1,883.39+$701.3KEDTXF
5$1,874,812$1,109,319.79$16,472$2,664.91+$1.86MEDTXF
6$4,722,949$2,716,900.45$20,024$3,897.79+$4.70MEDTXF
7$11,450,101$6,396,545.74$25,537$5,933.74+$11.42MEDTXF
8$26,744,592$14,492,983.16$34,478$9,476.77+$26.71MEDTXF
9$60,254,103$31,637,389.98$49,776$16,022.63+$60.20MEDTXF
10$131,086,199$66,614,308.55$77,699$28,968.54+$131.01MEDTXF

EDTXF vs MO: Complete Analysis 2026

EDTXFStock

Spectral Medical Inc., together with its subsidiaries, focuses on the development and commercialization of products for the treatment of septic shock and renal disease in North America. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops and manufactures monoclonal and polyclonal antibodies, recombinant cardiac proteins, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies; and develops platform for renal replacement therapy. The company was formerly known as Spectral Diagnostics Inc. and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was incorporated in 1991 and is headquartered in Toronto, Canada.

Full EDTXF Calculator →

MOConsumer Staples

Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. The company provides cigarettes primarily under the Marlboro brand; cigars and pipe tobacco principally under the Black & Mild brand; and moist smokeless tobacco products under the Copenhagen, Skoal, Red Seal, and Husky brands, as well as provides on! oral nicotine pouches. It sells its tobacco products primarily to wholesalers, including distributors; and large retail organizations, such as chain stores. Altria Group, Inc. was founded in 1822 and is headquartered in Richmond, Virginia.

Full MO Calculator →
📬

Get this EDTXF vs MO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EDTXF vs SCHDEDTXF vs JEPIEDTXF vs OEDTXF vs KOEDTXF vs MAINEDTXF vs PMEDTXF vs BTIEDTXF vs PG

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.